FB102 is an antibody designed to block interleukin-2 (IL-2) and interleukin-15 (IL-15). In celiac disease patients, gluten consumption results in the production of IL-2 and IL-15 which triggers intestinal inflammation, leading to destruction of intestinal cells. The goal of FB102 is to reduce intestinal damage and symptoms attributed to celiac disease after gluten consumption.
